Text Size: a  |   a 

MS Drug found to Reverse Disease's Early Physical Symptoms

October 17, 2016

New research suggests that introduction of Multiple Sclerosis agent Alemtuzumab could potentially improve some physical inabilities linked to the disease. This drug is known as a “disease modifier” which is believed to reduce the severity of relapses that individuals with MS experience.

Although it possesses rather severe side effects, Alemtuzumab is given to a person who has not responded well to other medications since it can destroy certain types of cells in the body that can cause more damage to the nerves. Despite the risks, however, the drug has proven to be quite prolific in the MS community.

Study lead author Dr. Gavin Giovannoni, Ph.D., of Queen Mary University of London in the United Kingdom, revealed that although a considerable amount of research has been done to slow down the progress of the disease, little is still known about reversing its side effects and the ability of current treatments to help in restoring the lost functions in the body.

Dr. Giovannoni concludes that although Alemtuzumab can cause the decline and severity of MS, a considerable amount of study must still be observed since it also poses a great risk of serious and rarely fatal autoimmune problems, as well as infusion reactions.